Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia

BACKGROUND: In June 2020, a large randomised controlled clinical trial in the UK found that dexamethasone was effective in reducing the number of deaths in patients with severe coronavirus disease 2019 (COVID-19). CASE DESCRIPTION: We describe a patient with rapid worsening of COVID-19 pneumonia and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruch, Yvon, Kaeuffer, Charlotte, Guffroy, Aurélien, Lefebvre, Nicolas, Hansmann, Yves, Danion, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350974/
https://www.ncbi.nlm.nih.gov/pubmed/32665942
http://dx.doi.org/10.12890/2020_001822
Descripción
Sumario:BACKGROUND: In June 2020, a large randomised controlled clinical trial in the UK found that dexamethasone was effective in reducing the number of deaths in patients with severe coronavirus disease 2019 (COVID-19). CASE DESCRIPTION: We describe a patient with rapid worsening of COVID-19 pneumonia and its dramatic improvement under corticosteroids. DISCUSSION: Corticosteroids could be useful in patients with an inflammatory profile, considering that acute respiratory distress syndrome may be the consequence of cytokine storm syndrome. LEARNING POINTS: One of the main pathophysiological hypotheses for severe COVID-19 pneumonia is inappropriate immunological hyperactivation. Corticosteroid therapy may be useful in these patients.

Ejemplares similares